Start-up delivers medical sterilisation at point of production

Start-up, EnXray’s medical equipment sterilisation technology is being commercialised with the support of collaborative manufacturing company, Tharsus

The technology will enable medical equipment manufacturers to sterilise medical devices at the point of production, according to Tharsus.

Currently, devices go through a process of ‘terminal sterilisation’ where products are shipped to a third-party for the process to be carried out before they are returned to the manufacturer for verification. 

EnXray founders Sergey Mitko, Yuri Udalov and Edward Cappabianca have developed a patented technology that generates high voltage, low energy x-rays to achieve the kilogray dosage of ionising radiation needed to ensure that devices can be deemed sterile.

Tharsus has signed a development partnership agreement with EnXray to produce a prototype device and subsequently deploy the commercial device across the medical technology sector.

Brian Palmer, chief executive of Tharsus, said: “This is a ground-breaking innovation that will have a significant impact on the way medical equipment is manufactured.

“Tharsus will tackle the complexities that come with the realisation of EnXray’s latest innovation, mitigating risk and generating a commercially successful product based on the company’s Intellectual Property.  

“Our knowledge-based approach to new product creation enables our engineers to realise EnXray’s insight into its market, which will deliver a scalable system that will be manufactured for the global medical industry.”

Edward Cappabianca, co-founder of EnXray, said: “Partnering with Tharsus is a significant element of the evolution of our expertise in medical sterilisation. 

“Their specialism in the commercialisation of high value, electro-mechanical products will help us bring a new solution in the med-tech field that will meet the requirements of medical device OEMs.”